{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:30:13Z","timestamp":1792639813497,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T00:00:00Z","timestamp":1575504000000},"content-version":"vor","delay-in-days":4631,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1093\/annonc\/mdl466","type":"journal-article","created":{"date-parts":[[2007,1,18]],"date-time":"2007-01-18T01:24:52Z","timestamp":1169083492000},"page":"652-657","source":"Crossref","is-referenced-by-count":106,"title":["The results of consolidation with autologous stem-cell transplantation in patients with peripheral T-cell lymphoma (PTCL) in first complete remission: the Spanish Lymphoma and Autologous Transplantation Group experience"],"prefix":"10.1016","volume":"18","author":[{"given":"J.","family":"Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Conde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Arranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1.","family":"Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bendandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Albo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.D.","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdl466_bb0010","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1182\/blood.V89.12.4514","article-title":"Evaluation of the Revised European-American Lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma","volume":"89","author":"Melnyk","year":"1997","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdl466_bb0015","first-page":"76","article-title":"Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA)","volume":"92","author":"Gisselbrecht","year":"1998","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdl466_bb0020","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1200\/JCO.1989.7.12.1783","article-title":"Clinical significance of immunophenotype in diffuse aggressive non-Hodgkin's lymphoma","volume":"7","author":"Armitage","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl466_bb0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/oxfordjournals.annonc.a057673","article-title":"Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. The GELA (Groupe d'Etude des Lymphomes Agressives)","volume":"1","author":"Coiffier","year":"1990","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdl466_bb0030","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1182\/blood.V106.11.811.811","article-title":"International peripheral T-cell lymphoma (PTCL) clinical and pathologic review project: poor outcome by prognostic indices and lack of efficacy with anthracyclines","volume":"106","author":"Vose","year":"2005","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdl466_bb0035","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1200\/JCO.2001.19.17.3766","article-title":"Impact of high-dose chemotherapy on peripheral T-cell lymphomas","volume":"19","author":"Rodriguez","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl466_bb0040","first-page":"646a","article-title":"Similar outcomes for chemosensitive (CS) relapsed or primary refractory peripheral T-cell lymphoma (PTCL) and diffuse large B-cell lymphoma (DLBCL) treated with autologous transplantation (ASCT)","volume":"100","author":"Kewalramani","year":"2002","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdl466_bb0045","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/annonc\/mdg008","article-title":"High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group","volume":"14","author":"Caballero","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdl466_bb0050","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/sj.bmt.1702867","article-title":"High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas","volume":"27","author":"Blystad","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdl466_bb0055","first-page":"987","article-title":"The International Non-Hodgkin's Lymphoma Prognostic Factors Project","volume":"329","author":"A predictive model for aggressive non-Hodgkin's lymphoma","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdl466_bb0060","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/oxfordjournals.annonc.a058324","article-title":"A proposal for a simple staging system for intermediate grade lymphoma and immunoblastic lymphoma based on the \u2018tumor score","volume":"3","author":"Rodriguez","year":"1992","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdl466_bb0065","first-page":"v56","article-title":"Long-term follow-up of autologous stem cell transplantation (ASCT) in patients with peripheral T-cell lymphoma (PTCL): the Spanish Lymphoma Cooperative Group (GEL-TAMO) experience","volume":"16","author":"Rodriguez","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdl466_bb0070","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","article-title":"Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study","volume":"103","author":"Gallamini","year":"2004","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdl466_bb0075","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1093\/annonc\/mdl466_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bjc.1977.1","article-title":"Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples","volume":"35","author":"Peto","year":"1977","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdl466_bb0085","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc"},{"key":"10.1093\/annonc\/mdl466_bb0090","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1182\/blood.V93.11.3913","article-title":"Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma","volume":"93","author":"Gascoyne","year":"1999","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdl466_bb0095","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1200\/JCO.2004.12.032","article-title":"Prognostic factors in patients with aggressive non-Hodgkin's lymphoma treated by front-line autotransplantation after complete remission: a cohort study by the Groupe d'Etude des Lymphomes de l'Adulte","volume":"22","author":"Mounier","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl466_bb0100","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1182\/blood.V106.11.2074.2074","article-title":"Autologous stem cell transplantation as first-line therapy in peripheral T-cell lymphomas. A prospective multicenter study","volume":"106","author":"Reimer","year":"2005","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdl466_bb0105","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1182\/blood.V106.11.2077.2077","article-title":"Intensive chemotherapy (high-dose CHOP\/ESHAP regimen) followed by autologous stem-cell transplantation (ASCT) in previously untreated patients with peripheral T-cell lymphoma (PTCL). Results of a prospective phase II study from the GELCAB","volume":"106","author":"Lopez-Guillermo","year":"2005","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdl466_bb0110","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1182\/blood.V104.11.909.909","article-title":"Long-term follow-up of high-dose chemotherapy followed by autologous stem cell transplantation in peripheral T-cell lymphomas at diagnosis","volume":"104","author":"Cortelazzo","year":"2004","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdl466_bb0115","first-page":"v15","article-title":"High-dose therapy and autologous stem cell transplant as first line treatment in peripheral T-cell lymphomas","volume":"16","author":"D'Amore","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdl466_bb0120","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1182\/blood.V90.9.3727","article-title":"Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome","volume":"90","author":"Tilly","year":"1997","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdl466_bb0125","first-page":"2697","article-title":"ALK+ lymphoma: clinico-pathological findings and outcome","volume":"93","author":"Falini","year":"1999","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdl466_bb0130","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/path.1331","article-title":"ALK-negative systemic anaplastic large cell lymphoma: differential diagnostic and prognostic aspects\u2014a review","volume":"200","author":"ten Berge","year":"2003","journal-title":"J Pathol"},{"key":"10.1093\/annonc\/mdl466_bb0135","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1182\/blood.V106.11.2681.2681","article-title":"Results of a phase II study of 506U78 (Nelarabine) in refractory indolent B-Cell or peripheral T-cell lymphoma","volume":"106","author":"Thompson","year":"2005","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdl466_bb0140","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1182\/blood-2003-09-3068","article-title":"T-cell lymphoma as a model for the use of histone deacetylase inhibitors in cancer therapy: impact of depsipeptide on molecular markers, therapeutic targets, and mechanisms of resistance","volume":"103","author":"Piekarz","year":"2004","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdl466_bb0145","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0092-8674(00)00117-3","article-title":"TOR, a central controller of cell growth","volume":"103","author":"Schmelzle","year":"2000","journal-title":"Cell"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419378652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419378652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/18\/4\/652\/307900\/mdl466.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T02:21:24Z","timestamp":1736734884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419378652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0923753419378652"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdl466","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}